Apollo Endosurgery (APEN) Misses Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St turns lower as crude spikes, chip stocks weigh
- Oil jumps 5%, then pares gains after Trump says no attack on Iran this month
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts APEN Hot Sheet
Join SI Premium – FREE
Apollo Endosurgery (NASDAQ: APEN) reported Q2 EPS of ($0.53), $0.09 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $15.8 million versus the consensus estimate of $16.64 million.
For earnings history and earnings-related data on Apollo Endosurgery (APEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Potential Starbucks-Chipotle merger: major opportunity or expensive distraction?
- PepsiCo (PEP) Tops Q3 EPS by 4c, cuts EPS forecast
- AngioDynamics (ANGO) Tops Q1 EPS by 7c, Beats on Revenue; Offers F27 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
